Cargando…
What did we learn about tocilizumab use against COVID-19? A single-center observational study from an intensive care unit in Serbia
BACKGROUND: Selection of effective and safe therapy for management of patients with coronavirus disease is challenging. Tocilizumab (TZB) has emerged as a potential treatment option for COVID-19. Several aspects regarding Tocilizumab treatment remain uncertain, such as the optimal timing for its adm...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683091/ https://www.ncbi.nlm.nih.gov/pubmed/38034537 http://dx.doi.org/10.3389/fmed.2023.1253135 |